NEWS & UPDATES
NEILL APPOINTED ACADEMIC IN RESIDENCE AT THE NATIONAL MEASUREMENT LABORATORY
April, 2023
As part of the growing partnership with NML, Neill has been appointed Academic in residence at NML. He will give his inaugural presentation in May, in London. This follows on from the appointment of the group's long-time collaborator, Dr Heidi Goenaga-Infante, as an honorary senior research fellow at the University of Liverpool
NANOMED EUROPE 2023 HOSTED BY THE UNIVERSITY OF LIVERPOOL
June 19-22, 2023
We are organising, and hosting, the annual ETPN scientific conference at the University of Liverpool!
​
Join us, and the nanomedicine community, to discuss the latest research in the field in conjunction with regulatory agencies such as the FDA and MHRA.
​
In particular, Neill will be chairing the session on Biosafety and Nanotoxicology.
​
Registration, and abstract submission, are now open!
INVITED PRESENTATION AT MALVERN PANALYTICAL ANNUAL CONFERENCE
April 26, 2023
Neill has been invited to talk on the group's research at the annual Malvern Panalytical Conference. His talk is titled "Assessing immunological responses to next-gen vaccine candidate delivery systems – the links to Physical and chemical characteristics"
THE IMMUNOCOMPATIBILITY GROUP HOSTS SINPAIN 1ST PROGRESS MEETING
14-15th December, 2022
We were delighted to host the siNPAIN partners, in Liverpool, for our first progress meeting. We discussed all of the work packages, and planned for 2023, and enjoyed meeting face-to-face. Learn more about the project at the link below.
PRESENTATION AT THE APS MEETING, BELFAST UK
September, 2022
Neill gave an invited talk, titled "Interactions between the immune system and nano(bio)materials - linking PCC to biological events", based on the group's work in investigating possible adverse events to complex medicines.
FUNDING AWARDED, TO SUPPORT RESEARCH AT THE INTERFACE BETWEEN IMMUNOLOGY AND MATERIALS SCIENCES
March 24th, 2022
In collaboration with the National Measurement Laboratory (NML), we have been awarded funding to develop, further, our 3D model of human skin. Key to the development of long-acting therapeutics, we aim to apply this model to simulate subcutaneous administration of long-acting formulations, to explore immunological and pharmacological responses to drug depots.
BRITISH TOXICOLOGICAL SOCIETY ANNUAL MEETING 2022
4th April 2022
Beth and Alex presented their work at the annual BTS meeting, in Gateshead.
CLINAM 2020
25th October 2020
Neill presented, on behalf of the team, our work linking concentration-dependant and concentration independant factors in the consideration of nanoparticle immunocompatibility. The meeting was great and the videos will be available early 2021